NPPA approves prices of 25 new drugs, opines compulsory regn & standardisation of medical devices
The National Pharmaceutical Pricing Authority (NPPA) has approved retail prices of 25 new drugs under the Drug Price Control Order (DPCO) 2013, in a meeting held in the end of July, 2021. The Authority meeting also opined that compulsory registration and standardisation of the products are required
NPPA Approves Prices Of 25 New Drugs, OpinNPPA App | 06/08/2021 | By Darshana | 170
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy